Description

Ethyl 3-Bromo-6-Nitroimidazo[1,2-A]Pyridine-2-Carboxylate is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, serving as a critical building block for novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of new therapeutic agents, particularly within oncology and anti-infective drug discovery programs.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• API Synthesis: Serves as a core scaffold for constructing complex molecules with potential biological activity in oncology and anti-infective fields.
• Chemical Biology Probes: Utilized in the development of molecular probes to study biological processes and identify new drug targets.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Employed in university and institutional labs for fundamental research in heterocyclic chemistry and drug discovery methodologies.

Basic Information

Product Name	Ethyl 3-Bromo-6-Nitroimidazo[1,2-A]Pyridine-2-Carboxylate
CAS No.	1198569-36-6
Molecular Formula	C10H8BrN3O4
Molecular Weight	314.10 g/mol
Synonyms	Ethyl 3-bromo-6-nitroimidazo[1,2-a]pyridine-2-carboxylate; 2-Imidazo[1,2-a]pyridinecarboxylic acid, 3-bromo-6-nitro-, ethyl ester; 3-Bromo-6-nitroimidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester; Ethyl 3-bromo-6-nitro-imidazo[1,2-a]pyridine-2-carboxylate; 1198569-36-6; Imidazo[1,2-a]pyridine-2-carboxylic acid, 3-bromo-6-nitro-, ethyl ester
EINECS	Contact for details

Quality Control

Our Ethyl 3-Bromo-6-Nitroimidazo[1,2-A]Pyridine-2-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our commitment to quality supports compliance with cGMP standards where required for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flame. Due to its light-sensitive nature, handling and storage should minimize exposure to direct light.

Specification

Item	Specification
Appearance	Yellow to brown crystalline powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.